← Back to Search

Platinum Complex

BBR 3464 for Pancreatic Cancer

Phase 2

Waitlist Available

Research Sponsored by Theradex

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No arrhythmia

Age: 18 and over

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is studying how well BBR 3464 works in treating patients with pancreatic cancer.

Who is the study for?

This trial is for adults with pancreatic cancer that's advanced or spread and can't be operated on. They should have not received treatment before, have at least one measurable tumor (not in previously treated areas), and be generally well enough to perform daily activities without help. People with certain blood conditions, recent heart attacks, uncontrolled heart disease, serious illnesses including infections, a history of severe diarrhea disorders like Crohn's disease or ulcerative colitis, pregnant or breastfeeding women, and those not using effective contraception are excluded.Check my eligibility

What is being tested?

The study is testing the effectiveness of a chemotherapy drug called BBR 3464 in patients with advanced pancreatic cancer that cannot undergo surgery. It's a Phase II trial which means it focuses on how well the drug works and further evaluates its safety.See study design

What are the potential side effects?

While specific side effects for BBR 3464 aren't listed here, common side effects from chemotherapy drugs include nausea and vomiting, fatigue, increased risk of infection due to low blood cell counts, hair loss, mouth sores and diarrhea.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have an irregular heartbeat.

Select...

I am 18 years old or older.

Select...

I can carry out all my usual activities without help.

Select...

I do not have any major neurological or psychiatric disorders, except those caused by my cancer.

Select...

I do not have any infections that aren't under control.

Select...

My condition has not been treated before.

Select...

I do not have any serious illnesses besides my current condition.

Select...

My cancer is a type of pancreatic cancer confirmed by lab tests.

Select...

My blood pressure is under control.

Select...

My cancer cannot be removed by surgery and has spread.

Select...

My kidney function is normal or only slightly reduced.

Select...

I do not have chest pain due to heart issues.

Select...

I do not have congestive heart failure.

Select...

I have not had a heart attack in the last year.

Select...

I do not have a history of chronic diarrhea conditions like Crohn's or ulcerative colitis.

Select...

My nutritional health is good enough to handle severe diarrhea.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 16Eligibility criteria met

Find a Location

Who is running the clinical trial?

TheradexLead Sponsor

33 Previous Clinical Trials

1,562 Total Patients Enrolled

George L. Miller, MDStudy ChairOklahoma Oncology, Incorporated at LaFortune Cancer Center

Media Library

BBR 3464 (Platinum Complex) Clinical Trial Eligibility Overview. Trial Name: NCT00024362 — Phase 2

Pancreatic Cancer Research Study Groups:

Pancreatic Cancer Clinical Trial 2023: BBR 3464 Highlights & Side Effects. Trial Name: NCT00024362 — Phase 2

BBR 3464 (Platinum Complex) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00024362 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any open slots available for this experiment?

"This specific clinical trial, which was last updated over a decade ago, is not currently looking for new participants. However, there are 726 other medical studies that are recruiting patients right now."

Answered by AI

Does the FDA sanction this medication?

"While there is some data to support the safety of this treatment, it receiving a score of 2. This is due to the fact that this medication is still in Phase 2 clinical trials and, as such, there has been no research indicating its efficacy."

Answered by AI

How many hospitals are participating in this experiment?

"Currently, this study is being conducted at the Albert B. Chandler Medical Center in Lexington, Kentucky; Alta Bates Comprehensive Cancer Center in Berkeley, California; and Arizona Oncology Associates in Tucson, Arizona--amongst 9 other locations."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

2001. "BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00024362.